Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy

Double-hit (DHL) and double expressor (DEL) DLBCL have poor prognosis with standard therapy but CART may overcome this poor prognostic impact. In this multicenter retrospective study, we sought to confirm this observation by evaluating survival outcomes among patients with relapsed/refractory DHL an...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Blood cancer journal (New York) Ročník 15; číslo 1; s. 43 - 7
Hlavní autori:	Karmali, Reem, Shouse, Geoffrey, Torka, Pallawi, Moyo, Tamara K., Romancik, Jason, Barta, Stefan K., Bhansali, Rahul, Cohen, Jonathon B., Shah, Nirav N., Zurko, Joanna, Kenkre, Vaishalee P., Hess, Brian, Stephens, Deborah M., Fitzgerald, Lindsey, Ollila, Thomas, Tabiti, Bukky, Roy, Ishan, Ma, Shuo, Winter, Jane, Pro, Barbara, Moreira, Jonathan, Danilov, Alexey V., David, Kevin, Gordon, Leo I., Epperla, Narendranath
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Nature Publishing Group UK 26.03.2025 Springer Nature B.V Nature Publishing Group
Predmet:	692/699/1541/1990/291/1621/1915 692/699/67/1059/2325 692/700/565/251 Adult Aged Aged, 80 and over Antigens, CD19 - immunology Biomedical and Life Sciences Biomedicine Cancer Research Female Hematology Humans Immunotherapy, Adoptive - adverse effects Immunotherapy, Adoptive - methods Lymphoma, Large B-Cell, Diffuse - genetics Lymphoma, Large B-Cell, Diffuse - immunology Lymphoma, Large B-Cell, Diffuse - mortality Lymphoma, Large B-Cell, Diffuse - therapy Male Medical prognosis Middle Aged Oncology Prognosis Receptors, Chimeric Antigen Retrospective Studies Treatment Outcome Young Adult
ISSN:	2044-5385, 2044-5385
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!